Please use this identifier to cite or link to this item:
http://nopr.niscpr.res.in/handle/123456789/43423Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Gokhale, Pratibha | - |
| dc.contributor.author | Kannan, Sudha | - |
| dc.date.accessioned | 2018-01-12T09:45:45Z | - |
| dc.date.available | 2018-01-12T09:45:45Z | - |
| dc.date.issued | 2017-12 | - |
| dc.identifier.issn | 0975-2404 (Online); 0972-5423 (Print) | - |
| dc.identifier.uri | http://nopr.niscair.res.in/handle/123456789/43423 | - |
| dc.description | 260-267 | en_US |
| dc.description.abstract | Although patent filing is increasing worldwide, it does not follow a uniform growth trend. China and South Korea have seen a substantial growth in patent filing as compared to developed nations. Regarding India, the growth is minimal. The trend reveals that more patents in India are filed for formulations, dosage forms, combination drugs and mode of delivery. New drug discovery has moved away from chemical entities to biological moieties. India, though known for its significant contribution to pharmaceutical industry by way of generic drugs is yet to make a meaningful presence in the patent scenario. | en_US |
| dc.language.iso | en_US | en_US |
| dc.publisher | NISCAIR-CSIR, India | en_US |
| dc.rights |  CC Attribution-Noncommercial-No Derivative Works 2.5 India | en_US |
| dc.source | ALIS Vol.64(4) [December 2017] | en_US |
| dc.subject | Patents | en_US |
| dc.subject | Pharmaceutical industry | en_US |
| dc.subject | Patent filing | en_US |
| dc.title | Patenting trends in Indian pharmaceutical industry | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | ALIS Vol.64(4) [December 2017] | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| ALIS 64(4) 260-267.pdf | 693.93 kB | Adobe PDF | View/Open |
Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.